| Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial | Ophthalmology |  | | 2016 | 1,233 | 300 |
|
| Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A | Acta ophthalmologica |  | | 2009 | 533 | 0 |
|
| A review of in vivo animal studies in retinal prosthesis research | Graefe's archive for clinical and experimental ophthalmology | | | 2008 | 680 | 709 |
|
